Maxim Group Downgrades Zivo Bioscience to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Anthony Vendetti has downgraded Zivo Bioscience from Buy to Hold.

June 04, 2024 | 3:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Maxim Group analyst Anthony Vendetti has downgraded Zivo Bioscience from Buy to Hold, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by a reputable analyst suggests a less favorable view on Zivo Bioscience's near-term performance, likely leading to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100